ZIOP
ZIOPHARM Oncology Inc
Price:  
0.87 
USD
Volume:  
2,139,210.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ZIOP WACC - Weighted Average Cost of Capital

The WACC of ZIOPHARM Oncology Inc (ZIOP) is 4.5%.

The Cost of Equity of ZIOPHARM Oncology Inc (ZIOP) is 5.25%.
The Cost of Debt of ZIOPHARM Oncology Inc (ZIOP) is 5.00%.

Range Selected
Cost of equity 4.60% - 5.90% 5.25%
Tax rate 27.00% - 27.00% 27.00%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.1% - 4.8% 4.5%
WACC

ZIOP WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 4.2% 5.2%
Adjusted beta 0.33 0.34
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.60% 5.90%
Tax rate 27.00% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.1% 4.8%
Selected WACC 4.5%